Figure 3.
In-vitro release of rivastigmine (RIVA) from different liposome formulations in comparison to control solution (4 mg/mL) through cellulose membrane in phosphate-buffered saline (pH 7.4).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.